Upgrade to SI Premium - Free Trial

Oragenics (OGEN)

0.51 0.00 (0.00%)

Chart
Today 6M 1Y 5Y

Latest Headlines

Form 4 ORAGENICS INC For: Jul 01 Filed by: Spencer John July 7, 2026 5:51 PM - SEC Filing Form 3 ORAGENICS INC For: Jul 01 Filed by: Spencer John July 7, 2026 5:44 PM - SEC Filing Form 8-K ORAGENICS INC For: Jun 29 July 6, 2026 4:06 PM - SEC Filing Form DEFA14A ORAGENICS INC May 20, 2026 4:11 PM - SEC Filing Form DEF 14A ORAGENICS INC For: May 20 May 20, 2026 4:06 PM - SEC Filing Oragenics to Present at Sidoti’s Micro-Cap Virtual Investor Conference May 20-21 May 19, 2026 8:45 AM - Globe NewsWire Form 8-K ORAGENICS INC For: May 18 May 19, 2026 8:39 AM - SEC Filing Oragenics advances ONP-002 trial in Australia, signs device licensing deal May 18, 2026 8:31 AM - StreetInsider ORAGENICS PROVIDES INVESTOR UPDATE May 18, 2026 8:30 AM - Globe NewsWire Form PRE 14A ORAGENICS INC For: May 08 May 8, 2026 4:06 PM - SEC Filing Form 10-Q ORAGENICS INC For: Mar 31 May 8, 2026 4:02 PM - SEC Filing Oragenics signs letter of intent to license blood purification technology May 7, 2026 8:30 AM - StreetInsider Oragenics Signs Letter of Intent to License CardioDialysis™ Technology from Sigyn Therapeutics to Target TBI-Induced Systemic Inflammation May 7, 2026 8:30 AM - Globe NewsWire Form 8-K ORAGENICS INC For: May 07 May 7, 2026 8:15 AM - SEC Filing Oragenics activates second site for ONP-002 brain injury trial May 5, 2026 8:31 AM - StreetInsider Oragenics Activates Second Site in Phase IIa Clinical Trial of ONP-002 for Concussion and Mild Traumatic Brain Injury. May 5, 2026 8:30 AM - Globe NewsWire Full Article List